Jonas Forsberg - Enzymatica Publ Director
| ENZY Stock | SEK 3.62 0.18 4.74% |
Director
Mr. Jonas E. Forsberg no longer serves as Independent Director at Enzymatica AB effective as of May 25 2016. He has held this position since April 21 2015. He is Vice PresidentGlobal Online Sales and Marketing Jabra . His former positions include Senior Director Product Management at GN Netcom and Marketing and Sales positions within Sony Ericsson Mobile Communications and Ericsson. He holds Executive MBA degree. since 2015.
| Age | 38 |
| Tenure | 9 years |
| Professional Marks | MBA |
| Phone | 46 4 62 86 31 00 |
| Web | https://www.enzymatica.se |
Enzymatica Publ Management Efficiency
The company has return on total asset (ROA) of (0.1909) % which means that it has lost $0.1909 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4032) %, meaning that it generated substantial loss on money invested by shareholders. Enzymatica Publ's management efficiency ratios could be used to measure how well Enzymatica Publ manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 13 records | DIRECTOR Age | ||
| Mats Blom | Hansa Biopharma AB | 53 | |
| Corinne Savill | Cantargia AB | 59 | |
| Patricia Delaite | Cantargia AB | 53 | |
| Andreas Eggert | Hansa Biopharma AB | 50 | |
| Birgit Norinder | Hansa Biopharma AB | 69 | |
| Karin Leandersson | Cantargia AB | 43 | |
| Niclas Lundqvist | Cantargia AB | 50 | |
| Thoas Fioretos | Cantargia AB | 53 | |
| Anders Pedersen | Hansa Biopharma AB | 66 | |
| Anders MartinLof | Cantargia AB | 48 | |
| Claus Andersson | Cantargia AB | 51 | |
| Lars Larsson | Cantargia AB | 62 | |
| Eva Nilsagard | Hansa Biopharma AB | 54 | |
Management Performance
| Return On Equity | -0.4 | |||
| Return On Asset | -0.19 |
Enzymatica publ AB Leadership Team
Elected by the shareholders, the Enzymatica Publ's board of directors comprises two types of representatives: Enzymatica Publ inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Enzymatica. The board's role is to monitor Enzymatica Publ's management team and ensure that shareholders' interests are well served. Enzymatica Publ's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Enzymatica Publ's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jonas Forsberg, Director | ||
| Bengt Baron, Independent Chairman of the Board | ||
| Mats Clarsund, Executive Vice President for Research and Development | ||
| Stefan Olsson, Communication Mang | ||
| Anders Jungbeck, Director | ||
| Nils Siegbahn, Director | ||
| Bengt Jondell, Acting CFO | ||
| Claus Egstrand, Chief Commercial Officer | ||
| Sigurgeir Gudlaugsson, Director | ||
| Ulf Blom, Executive Vice President Marketing and Operations | ||
| Gun Rydhog, Director of Quality and Regulatory Management | ||
| Louise Nicolin, Director | ||
| Anna Isaksson, Vice President Quality and Regulatory Management | ||
| Therese Filmersson, Chief Financial Officer | ||
| Monica Wallter, Director | ||
| Marianne Alexandersson, Independent Director | ||
| Hans Pihl, Director | ||
| Gudmundur Palmason, Director | ||
| Jorgen Rexo, Executive Vice President Legal, Director | ||
| Mats Andersson, Director | ||
| Fredrik Lindberg, Chief Executive Officer | ||
| Lennart Nilsson, Chairman of the Board | ||
| Johan Lindvall, Chief Operating Officer, Executive Vice President | ||
| Johan Wennerholm, CFO |
Enzymatica Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Enzymatica Publ a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.4 | |||
| Return On Asset | -0.19 | |||
| Profit Margin | (1.12) % | |||
| Operating Margin | (1.12) % | |||
| Current Valuation | 613.36 M | |||
| Shares Outstanding | 164.26 M | |||
| Shares Owned By Insiders | 64.15 % | |||
| Shares Owned By Institutions | 1.71 % | |||
| Price To Earning | (6.00) X | |||
| Price To Book | 47.25 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Enzymatica Publ in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Enzymatica Publ's short interest history, or implied volatility extrapolated from Enzymatica Publ options trading.
Pair Trading with Enzymatica Publ
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enzymatica Publ position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzymatica Publ will appreciate offsetting losses from the drop in the long position's value.Moving against Enzymatica Stock
| 0.65 | SEB-C | Skandinaviska Enskilda | PairCorr |
The ability to find closely correlated positions to Enzymatica Publ could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enzymatica Publ when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enzymatica Publ - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enzymatica publ AB to buy it.
The correlation of Enzymatica Publ is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enzymatica Publ moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enzymatica publ AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Enzymatica Publ can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzymatica publ AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Enzymatica Stock analysis
When running Enzymatica Publ's price analysis, check to measure Enzymatica Publ's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzymatica Publ is operating at the current time. Most of Enzymatica Publ's value examination focuses on studying past and present price action to predict the probability of Enzymatica Publ's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzymatica Publ's price. Additionally, you may evaluate how the addition of Enzymatica Publ to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |